Group 1 - The Shanghai Stock Exchange's Sci-Tech Innovation Board semiconductor materials and equipment index surged by 9.80% as of September 24, 2025, with notable increases in constituent stocks such as ShenGong Co. (up 20.01%), Shengmei Shanghai (up 15.90%), and Jingyi Equipment (up 15.03%) [1] - The Sci-Tech Semiconductor ETF (588170) rose by 9.50%, reaching a peak increase of 10% during trading, marking its third consecutive day of gains [1] - Over the past five days, the Sci-Tech Semiconductor ETF has seen continuous net inflows, with a maximum single-day net inflow of 136 million yuan, totaling 374 million yuan, averaging 7.49 million yuan in daily net inflows [1] Group 2 - The Sci-Tech Semiconductor ETF (588170) and its linked funds (Class A: 024417; Class C: 024418) track the Shanghai Stock Exchange's semiconductor materials and equipment index, encompassing hard-tech companies in semiconductor equipment (59%) and semiconductor materials (25%) [1] - The semiconductor equipment and materials industry is a significant area for domestic substitution, characterized by low domestic substitution rates and high potential for domestic replacement, benefiting from the expansion of semiconductor demand driven by the AI revolution, waves of technology restructuring and mergers, and advancements in lithography technology [1]

Group 1 - The A-share market shows strong performance in storage chip concept stocks, with Tongfu Microelectronics hitting the daily limit up [1] - Companies such as Jingyi Equipment, Saiteng Co., Jiangbolong, and Juchen Co. have seen stock increases of over 7% [1] - Yake Technology and Chengbang Co. have risen by over 6%, while Demingli has increased by over 5% [1] - Changdian Technology and Huahai Qingke have both experienced stock growth of over 4% [1]

Group 1 - The core viewpoint of the news is that Kangpeng Technology experienced a decline in stock price and significant changes in financing activities on September 23, with a net financing outflow of 9.55 million yuan [1] - On September 23, Kangpeng Technology's stock fell by 3.91%, with a trading volume of 106 million yuan, and the total financing and securities balance reached 94 million yuan, accounting for 4.46% of the circulating market value [1] - The company has a high financing balance, exceeding the 80th percentile level over the past year, indicating a potentially elevated risk in financing activities [1] Group 2 - As of June 30, the number of shareholders of Kangpeng Technology increased by 8.34% to 10,300, while the average circulating shares per person decreased by 7.69% to 24,740 shares [2] - For the first half of 2025, Kangpeng Technology reported a revenue of 436 million yuan, representing a year-on-year growth of 27.94%, and a net profit attributable to shareholders of 31.02 million yuan, which is a significant increase of 257.08% year-on-year [2] - Since its A-share listing, Kangpeng Technology has distributed a total of 34.28 million yuan in dividends [2]

Core Insights - The company reported a revenue of 436 million yuan for the first half of the year, representing a year-on-year growth of 27.94%, and a net profit attributable to shareholders of 31 million yuan, reflecting a significant increase of 257.08% [1] Group 1: Business Overview - The company has established itself as a global leader in the fine chemicals manufacturing sector, particularly excelling in fluorinated fine chemicals [2] - It has developed a global integrated research, production, and sales network with three main production bases in Shanghai, Zhejiang, and Lanzhou, alongside an international base in the USA [2] - The Lanzhou base is crucial for regional expansion and product diversification, enhancing the company's control over the supply chain in fluorinated chemicals and organic silicon [2] Group 2: Technological Advancements - Continuous R&D investment and key technological breakthroughs are the company's core competitive advantages, leading to the development of high-tech, high-value-added products [3] - The company is one of the first globally to achieve mass production of a new electrolyte for lithium batteries, significantly advancing the domestic production of high-quality lithium battery materials [3] - It has also developed a series of high-performance lithium battery electrolyte additives, achieving an average annual compound growth rate of over 40% in recent years [3] Group 3: Capacity Adjustment and Future Plans - The company plans to leverage its R&D support and brand influence to expand capacity and market reach, particularly through the Lanzhou base, which is projected to generate an annual sales revenue of 1 billion yuan upon full operation [4] - The company is adjusting its investment focus towards new materials and peptide pharmaceuticals, with specific projects aimed at enhancing production capabilities in these areas [5] - New projects include a 25,500-ton annual capacity battery materials project in Lanzhou, which has been adjusted to a 5,000-ton capacity for the first phase, and additional projects in Zhuzhou and Shanghai targeting new materials and peptide production [5]

上海市锦天城律师事务所 关于上海康鹏科技股份有限公司 2025 年第三次临时股东会的 法律意见书 关于上海康鹏科技股份有限公司 2025 年第三次临时股东会的 法律意见书 致：上海康鹏科技股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受上海康鹏科技股份有限 公司（以下简称"公司"）委托，就公司召开 2025 年第三次临时股东会（以下简 称"本次股东会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公 司法》"）《上市公司股东会规则》《上海证券交易所科创板股票上市规则》（以下 简称"《上市规则》"）等法律、法规和其他规范性文件以及《上海康鹏科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本法律意见书。 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 楼 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2025-053 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 9 月 15 日 （二） 股东会召开的地点：上海市普陀区祁连山南路 2891 弄 200 号 1 幢一楼会 议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 上海康鹏科技股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 二、 议案审议情况 （一） 非累积投票议案 1、 议案名称：《关于修订<公司章程>及部分管理制度的议案》 审议结果：通过 表决情况： | 1、出席会议的股东和代理人人数 | 120 | | --- | --- | | 普通股股东人数 | 120 | | 2、出席会议的股东所持有的表决权数量 | 266,692,508 | | 普通股股东所持有表决权数量 | 266,692,508 | | 3、出席会议的股东所持有表决权数量占公司 ...

中信建投证券股份有限公司 中国证券监督管理委员会出具《关于同意上海康鹏科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2023]1007 号），同意上海康鹏科技股份有限 公司（以下简称"公司"或"康鹏科技"）首次公开发行股票的注册申请。本次 公司发行新股的发行价为 8.66 元/股，募集资金总额为 899,557,500.0 元，扣除发 行费用 88,897,892.9（不含税金额）元后，实际募集资金净额为 810,659,607.10 元。中信建投证券股份有限公司（简称"中信建投证券"）担任本次公开发行股票 的保荐机构。根据《证券发行上市保荐业务管理办法》，由中信建投证券完成持 续督导工作，出具本持续督导跟踪报告。 2 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | | 持续关注上市公司及控股股东、实际控制 | | | | 人等履行承诺的情况，上市公司及控股股 | 本持续督导期间，康鹏科技及其控股股 | | 12 | 东、实际控制人等未履行承诺事项的，及 | 东不存在未履行承诺的情况 | | | 时向上海证券交易所报告。 | | | | 关注公共传媒关于上 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 09 月 18 日（星期四）15:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 证券代码：688602 证券简称：康鹏科技 公告编号：2025-052 上海康鹏科技股份有限公司 关于参加 2025 年半年度科创板新材料行业 集体业绩说明会的公告 本次业绩明会以网络互动形式召开，公司将针对 2025 年半年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一） 会议召开时间：2025 年 09 月 18 日（星期四）15:00-17:00 （ 二 ） 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadsho ...

Core Viewpoint - Kangpeng Technology reported significant growth in revenue and net profit for the first half of 2025, despite a decline in second-quarter performance due to falling battery material prices impacting the new materials segment [1][2]. Financial Performance - The company's revenue for H1 2025 was 436 million yuan, a year-on-year increase of 27.94% [1]. - Net profit attributable to shareholders was 31 million yuan, up 257.08% year-on-year, while the net profit excluding non-recurring items was 23 million yuan, an increase of 175.90% [1]. - In Q2 2025, revenue was 193 million yuan, a quarter-on-quarter decrease of 20.53%, and net profit was 387,700 yuan, down 98.73% quarter-on-quarter [1]. Segment Performance - Revenue from new materials and pharmaceutical and pesticide chemicals for H1 2025 was 155 million yuan and 262 million yuan, respectively, with year-on-year changes of -3.51% and +56.90% [2]. - Gross margins for these segments were 0.66% and 32.82%, reflecting changes of -1.82 and +4.08 percentage points, respectively [2]. - The growth in overall performance was primarily driven by the CDMO business, which benefited from industry and downstream customer order cycles [2]. Cash Flow and Financial Health - Operating cash flow for H1 2025 was 78 million yuan, a year-on-year increase of 197.20% [3]. - Investment cash flow was 206 million yuan, up 131.52% year-on-year, while financing cash flow was -39 million yuan, down 32.06% [3]. - The ending cash and cash equivalents balance was 968 million yuan, a year-on-year increase of 337.92% [3]. Project Development - The ETO project is running smoothly, with new capacity expected to gradually come online [3]. - Key ongoing projects include the production of various chemical products and materials, with significant expansions planned for 2026 [4]. - The company is optimistic about the gradual completion and production of these projects, which are expected to contribute to future performance [5]. Future Outlook - Revenue projections for 2025-2027 are 892 million yuan, 1.105 billion yuan, and 1.341 billion yuan, with year-on-year growth rates of 32.2%, 23.8%, and 21.4% respectively [5]. - Net profit forecasts for the same period are 64 million yuan, 180 million yuan, and 251 million yuan, with growth rates of 229.6%, 181.1%, and 38.9% respectively [5]. - The company maintains a "buy" rating based on the expected release of ETO capacity and its potential profit contribution [5].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [4][17]. Core Views - The company's performance is driven by the recovery of its CDMO business, with a notable increase in revenue and net profit in the first half of 2025. The revenue for 1H25 reached 436 million yuan, a year-on-year increase of 27.94%, while the net profit attributable to shareholders was 31 million yuan, up 257.08% year-on-year [1][2]. - The report highlights the impact of declining battery material prices on the overall profitability of the new materials segment, while the CDMO business shows significant growth due to industry and customer order cycles [2]. - The company has several ongoing projects that are expected to contribute to future earnings, including the ETO project, which is anticipated to gradually release production capacity [3][8]. Financial Summary - The projected revenue for the company from 2025 to 2027 is 892 million yuan, 1,105 million yuan, and 1,341 million yuan, respectively, with year-on-year growth rates of 32.2%, 23.8%, and 21.4% [9]. - The net profit attributable to shareholders is expected to be 64 million yuan, 180 million yuan, and 251 million yuan for the same period, with significant growth rates of 229.6%, 181.1%, and 38.9% [9]. - The report provides a detailed financial outlook, including projected EPS of 0.12 yuan, 0.35 yuan, and 0.48 yuan for 2025, 2026, and 2027, respectively [9].